CYMELL

  • Research type

    Research Study

  • Full title

    Collaborative communitY based education programme to reduce Inequalities in the uptake of diabetes screening among Minority Ethnic peopLe in WaLes: Phase I feasibility study

  • IRAS ID

    321512

  • Contact name

    Rose Stewart

  • Contact email

    rose.stewart@wales.nhs.uk

  • Sponsor organisation

    Betsi Cadwallader University Health Board

  • Duration of Study in the UK

    1 years, 5 months, 31 days

  • Research summary

    The number of people diagnosed with Type 2 diabetes is increasing worldwide. Unfortunately, people from ethnic minority backgrounds are at greater risk – up to five times more likely to develop diabetes than those who are ‘white’; they develop diabetes at a younger age, and they are more susceptible to developing long-term complications of diabetes. The long-term complications of diabetes are harmful, life limiting and costly to treat. To detect and treat these complications in early stages, the NHS has nine ways of testing and checking people with diabetes. People from ethnic minority backgrounds are especially unlikely to get these checks. So, finding new ways of increasing their access to these checks would enable the early treatment and detection of long-term complications, especially blindness, amputations and kidney disease.
    In the proposed study, we aim to do two things:
    1. To co-design and pilot a community-based checking/screening education program to be co-delivered by diabetes specialist nurses and community leaders and support workers, to improve diabetes health literacy and accessibility of diabetes checks/screening among people from ethnic minority backgrounds. Thereby increasing the uptake of checks/screening among underserved and hard to reach population.
    2. To determine the feasibility of a stepped wedge cluster trial design and data collection methods, so that we can make a decision about whether to proceed to a full trial, which can answer questions about whether the intervention is effective for patients and worthwhile for the NHS.

  • REC name

    Wales REC 3

  • REC reference

    23/WA/0083

  • Date of REC Opinion

    22 Feb 2023

  • REC opinion

    Favourable Opinion